# Thyroxine Replacement in Organ Donors

> **NCT00238030** · PHASE1,PHASE2 · COMPLETED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 34 (actual)

## Conditions studied

- Brain Death

## Interventions

- **DRUG:** L-thryoxine
- **DRUG:** iv thryoxine

## Key facts

- **NCT ID:** NCT00238030
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2009-05
- **Final completion:** 2010-10
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2011-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00238030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00238030, "Thyroxine Replacement in Organ Donors". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00238030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*